Hvis behandling med levetiracetam imidlertid er nødvendig under amning, skal fordele/ risici ved behandlingen afvejes i forhold til vigtigheden af amning.
However, if levetiracetam treatment is needed during breastfeeding, the benefit/ risk of the treatment should be weighed considering the importance of breastfeeding.